As of Feb 05
| -0.05 / -2.65%|
The 6 analysts offering 12-month price forecasts for Orexigen Therapeutics Inc have a median target of 5.00, with a high estimate of 11.00 and a low estimate of 2.00. The median estimate represents a +171.74% increase from the last price of 1.84.
The current consensus among 8 polled investment analysts is to Buy stock in Orexigen Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.